701-1111

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2012-09-07

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate ARTHRALGIA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-13 (study day 7.0); relationship: NONE

moderate assessed

Moderate CELLULITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-13 (study day 7.0); relationship: NONE

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

mild assessed

Mild ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

moderate assessed

Moderate LOCALISED INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-07-08 (study day -61.0); relationship: NONE

mild assessed

Mild MICTURITION URGENCY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-07 (study day 1.0); relationship: NONE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

mild assessed

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2012-09-02 (study day -5.0); relationship: NONE

Data queries

No data queries.